Company Profile

Samsara Vision, Inc is a specialty medical device company. The Company is involved in bringing vision and freedom back to patients suffering from late-stage conditions of the retina. It is engaged in the research, development, manufacturing, and marketing of ophthalmic devices and technologies that are intended to improve vision and quality of life for individuals with untreatable retinal disorders, particularly Age-Related Macular Degeneration (AMD). Its product line consists of its first-generation implantable miniature telescope (IMT), which it refers to as WA IMT; its Smaller-Incision, New Generation (SING) IMT, which it refers to as SING IMT; and its Tsert delivery system. Its WA IMT is the implantable medical device that works similarly to the telephoto lens of a camera, which enables improvement in vision and quality of life for individuals with the most advanced form of AMD, commonly referred to as late-stage AMD.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

25-10-16	Samsara Vision Expands U.S. and Puerto Rico Clinical Study Sites for the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT®?)	CI
25-10-06	Samsara Vision Announces First Pseudophakic Surgery in the Perspective Clinical Trial to Evaluate the Smaller-Incision New-Generation Implantable Miniature Telescope (Sing Imt) in Patients with Previous Cataract Surgery	CI
24-09-03	Samsara Vision, Inc. Promotes Jason Herod to Chief Commercial Officer	CI
24-07-22	Samsara Vision Announces First SING IMT (Smaller-Incision New-Generation Implantable Miniature Telescope) Patient in China and Accelerating Global Rollout	CI
22-07-11	Samsara Vision Announces First U.S. Surgeries of the Sing Imt, for Age-Related Macular Degeneration as Part of the Concerto Study	CI
22-06-08	Samsara Vision and Lansheng Medical “Myvision” Announce Collaboration to Commercialize the Sing Imt™ in China	CI
22-04-20	Samsara Vision, Inc. to Initiate A U.S. Pma Supplemental Study of the Sing Imt™, A New-Generation Technology for Age-Related Macular Degeneration	CI
22-03-11	Samsara Vision, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
22-03-10	Samsara Vision, Inc. Auditor Raises 'Going Concern' Doubt	CI
22-02-22	Samsara Vision, Inc. Announces the First Three Successful Clinical Cases in Italy Using Its Sing Imt™	CI
21-11-03	Samsara Vision, Inc. has filed an IPO.	CI
21-09-30	Samsara Vision, Inc. Auditor Raises 'Going Concern' Doubt	CI
16-03-10	VisionCare Ophthalmic Technologies, Inc. Announces Appointment of Thierry Clidiere to Board of Directors	CI

Manager	Title	Age	Since
Joshua Fox DFI	Director of Finance/CFO	55	2020-12-31
Rebecca Kammer CTO	Chief Tech/Sci/R&D Officer	-	2022-10-31
Doron Raz DFI	Director of Finance/CFO	-	1999-12-31

Director	Title	Age	Since
Thierry Clidiere BRD	Director/Board Member	74	2016-01-31
Jonathan H. Talamo BRD	Director/Board Member	64	2021-01-03
David Schiff BRD	Director/Board Member	53	2021-01-03

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAMSARA VISION, INC.	-.--%	-.--%	-	-	135M
ABBOTT LABORATORIES	-1.51%	-3.76%	-25.64%	+4.04%	175B
MEDTRONIC PLC	-0.49%	-2.95%	-9.00%	+11.44%	111B
STRYKER CORPORATION	-1.49%	+0.59%	-25.61%	+0.42%	107B
ESSILORLUXOTTICA	+1.00%	-2.60%	-47.08%	-10.76%	75.31B
CENCORA, INC.	-3.10%	-5.04%	-5.11%	+65.60%	58.7B
BECTON, DICKINSON AND COMPANY	-0.49%	-0.21%	-2.69%	-29.34%	49.57B
HOYA CORPORATION	+1.53%	+1.90%	+15.16%	+55.54%	49.27B
IDEXX LABORATORIES, INC.	-1.04%	+1.10%	-17.39%	+22.47%	42.02B
DEXCOM, INC.	-1.36%	-1.96%	+27.82%	-9.03%	32.69B
Average	-0.69%	-0.69%	-9.95%	+12.27%	77.84B
Weighted average by Cap.	-0.88%	-1.13%	-16.09%	+9.99%

Samsara Vision, Inc. Stock

Stocks

SMSA

US79600A1051

Medical Equipment, Supplies & Distribution

Latest news: Samsara Vision, Inc.

Managers and Directors: Samsara Vision, Inc.

Medical Devices & Implants

Company Profile